MAY 20, 2022 1:38 PM PDT

Drug Shows Promise in treating Spinal Cord Injury

WRITTEN BY: Annie Lennon

A drug developed by AstraZeneca preserves 80% of nerve function following spinal cord injury (SCI). The corresponding study was published in Clinical and Translational Medicine

"There is currently no reparative drug available for SCI patients. Treatments only provide symptomatic relief and do not tackle the underlying molecular mechanisms that cause or contribute to oedema and blood-spinal cord barrier breakdown, "said Professor Zubair Ahmed, Professor of Neuroscience and lead for the Neuroscience and Ophthalmology Section at The University of Birmingham, and lead author of the study. 

"This drug has the potential to be a first-in-class treatment against some of the key pathological drivers of SCI and could revolutionize the prospects for recovery of SCI patients," he added. 

The drug is called AZD1236, and is a selective inhibitor of two enzymes- MMP-9 and MMP-12- that play a role in the inflammatory process. In the present study, the researchers tested the drug in mouse models of spinal cord injury. 

In doing so, they found that AZD1236 led to an 85% improvement in movement and sensation after only three days of treatment, beginning 24 hours post-injury. They further found that at three weeks, mice treated with the drug showed an 'unprecedented' recovery. In contrast, control animals still demonstrated significant deficits at six weeks post-injury. 

In terms of biomarkers, the researchers found that oral dosing of AZD1236 reduced enzyme activity by 90% in serum and 69-74% in cerebrospinal fluid. Intrathecal injection- injection around the spinal cord- reduced enzyme activity by 88-90% in the cerebrospinal fluid. 

The drug also suppressed the production of pro-inflammatory cytokines- known to contribute to long-lasting neuropathic pain- by 85-95%, and was 82% more effective than current treatments such as pregabalin and gabapentin in reducing neuropathic sensitivity to cold, heat, and touch. 

"Exploring the potential of AZD1236 for this new indication represents a great outcome for our Open Innovations programme and aligns with our ethos of "sharing ideas and enabling scientific innovation to cross boundaries between academia and industry will help to translate innovative ideas into scientific breakthroughs and potential new medicines more quickly," said Hitesh Sanganee Ph.D, Head of Emerging Innovations at AstraZeneca. 

 

Sources: Clinical and Translational Medicine, Science Daily

 

 

About the Author
University College London
Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
APR 20, 2022
Cancer
"Saturating" the Liver with Chemotherapy to Treat Cancer
APR 20, 2022
"Saturating" the Liver with Chemotherapy to Treat Cancer
Uveal melanoma is a rare type of cancer that grows in the melanin, the dark-colored pigment of the eye. About  ...
MAY 25, 2022
Neuroscience
Exploring Drug Targets in Neurodegenerative Diseases
MAY 25, 2022
Exploring Drug Targets in Neurodegenerative Diseases
Introduction Life expectancy has increased globally over the last several decades. However, longer life expectancy comes ...
JUN 13, 2022
Cancer
Clinical Trial Demonstrates an Amazing 100% Response
JUN 13, 2022
Clinical Trial Demonstrates an Amazing 100% Response
The results of a Clinical Trial for rectal cancer patients published last week in the New England Journal of Medicine co ...
JUN 27, 2022
Cancer
A Genomic Scan Detects Cancer-Driving Mutations
JUN 27, 2022
A Genomic Scan Detects Cancer-Driving Mutations
Cancer develops when the DNA in our cells becomes altered, resulting in a gene mutation.  DNA alterations can occur ...
JUL 01, 2022
Cannabis Sciences
Firefly Genes Provide Insights into Cannabis Biology
JUL 01, 2022
Firefly Genes Provide Insights into Cannabis Biology
A team of University of Connecticut researchers are using firefly genes to understand molecular mechanisms involved in t ...
JUL 01, 2022
Coronavirus
Nanobodies Could Protect Us From Every Variant
JUL 01, 2022
Nanobodies Could Protect Us From Every Variant
Immune reactive molecules called nanobodies, which are based on molecules found in llamas could offer robust protection ...
Loading Comments...